Literature DB >> 21163596

Protective effect of lycopene on serum cholesterol and blood pressure: Meta-analyses of intervention trials.

Karin Ried1, Peter Fakler.   

Abstract

BACKGROUND: Cardiovascular disease is associated with oxidative stress, inflammatory processes, and vascular dysfunction. Lycopene, a carotenoid found in tomatoes, is an antioxidant with a protective effect on lipid peroxidation and anti-atherosclerotic capacity. This review summarises current evidence on the effect of lycopene on serum lipid concentrations and blood pressure.
METHODS: We searched the PubMed and Cochrane databases for intervention studies between 1955 and September 2010 investigating the effect of lycopene on blood lipids or blood pressure for a minimum duration of 2 weeks. We conducted meta-analyses using a random effect model of all studies fitting the inclusion criteria. Additionally, we conducted subgroup meta-analysis of serum lipid concentrations by lycopene dosage and subgroup meta-analysis by baseline blood pressure.
RESULTS: Twelve studies (13 trial arms) meeting the inclusion criteria investigated the effect of lycopene on serum lipids, and four studies examined its effect on blood pressure. Meta-analysis on serum lipids revealed a significant cholesterol-lowering effect of lycopene for total serum cholesterol (mean change±SE: -7.55±6.15mg/dl; p=0.02) and low-density-lipoprotein (LDL) cholesterol (mean change±SE: -10.35±5.64mg/dl, p=0.0003) in the subgroup of trials using lycopene dosages of ≥25mg daily, whereas subgroup meta-analysis of trials using lower lycopene dosages was not significant. Meta-analysis of the effect of lycopene on systolic blood pressure of all trials suggested a significant blood pressure reducing effect (mean systolic blood pressure change±SE: -5.60±5.26mm Hg, p=0.04).
CONCLUSIONS: Our meta-analysis suggests that lycopene taken in doses ≥25mg daily is effective in reducing LDL cholesterol by about 10% which is comparable to the effect of low doses of statins in patient with slightly elevated cholesterol levels. More research is needed to confirm suggested beneficial effects on total serum cholesterol and systolic blood pressure.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163596     DOI: 10.1016/j.maturitas.2010.11.018

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  36 in total

Review 1.  Nutraceuticals and Blood Pressure Control: Results from Clinical Trials and Meta-Analyses.

Authors:  Arrigo F G Cicero; Alessandro Colletti
Journal:  High Blood Press Cardiovasc Prev       Date:  2015-03-19

Review 2.  Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals.

Authors:  Arrigo F G Cicero; Claudio Borghi
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

3.  The CAPN2/CAPN8 Locus on Chromosome 1q Is Associated with Variation in Serum Alpha-Carotene Concentrations.

Authors:  Christopher R D'Adamo; Valerie J Dawson; Kathleen A Ryan; Laura M Yerges-Armstrong; Richard D Semba; Nanette I Steinle; Braxton D Mitchell; Alan R Shuldiner; Patrick F McArdle
Journal:  J Nutrigenet Nutrigenomics       Date:  2016-12-22

Review 4.  Recent Progress in Discovering the Role of Carotenoids and Their Metabolites in Prostatic Physiology and Pathology with a Focus on Prostate Cancer-A Review-Part I: Molecular Mechanisms of Carotenoid Action.

Authors:  Joanna Dulińska-Litewka; Yoav Sharoni; Przemysław Hałubiec; Agnieszka Łazarczyk; Oskar Szafrański; James A McCubrey; Bartosz Gąsiorkiewicz; Piotr Laidler; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-04-10

5.  Plant Foods, Antioxidant Biomarkers, and the Risk of Cardiovascular Disease, Cancer, and Mortality: A Review of the Evidence.

Authors:  Dagfinn Aune
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 6.  Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Br J Clin Pharmacol       Date:  2016-03-15       Impact factor: 4.335

7.  The association of antioxidants and cognition in the Nurses' Health Study.

Authors:  Elizabeth E Devore; Jae H Kang; Meir J Stampfer; Francine Grodstein
Journal:  Am J Epidemiol       Date:  2012-12-07       Impact factor: 4.897

8.  Relationship of lycopene intake and consumption of tomato products to incident CVD.

Authors:  Paul F Jacques; Asya Lyass; Joseph M Massaro; Ramachandran S Vasan; Ralph B D'Agostino
Journal:  Br J Nutr       Date:  2013-01-15       Impact factor: 3.718

9.  Lycopene stabilizes lipoprotein levels during D-galactosamine/lipopolysaccharide induced hepatitis in experimental rats.

Authors:  Sheik Abdulazeez Sheriff; Thiruvengadam Devaki
Journal:  Asian Pac J Trop Biomed       Date:  2012-12

Review 10.  Antioxidant-based therapies for angiotensin II-associated cardiovascular diseases.

Authors:  Erin G Rosenbaugh; Krupa K Savalia; Devika S Manickam; Matthew C Zimmerman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-04-03       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.